Heparin in Acute Embolic Stroke Trial - HAEST

Description:

Heparin in Acute Embolic Stroke Trial (HAEST) was a randomized trial comparing the effects of aspirin and dalteparin, a low molecular weight heparin, in patients with atrial fibrillation (AF) and acute ischemic stroke.